ATE314345T1 - N-substituierte benzyl oder phenyl arylsulfamide und ihre verwendung - Google Patents

N-substituierte benzyl oder phenyl arylsulfamide und ihre verwendung

Info

Publication number
ATE314345T1
ATE314345T1 AT00941870T AT00941870T ATE314345T1 AT E314345 T1 ATE314345 T1 AT E314345T1 AT 00941870 T AT00941870 T AT 00941870T AT 00941870 T AT00941870 T AT 00941870T AT E314345 T1 ATE314345 T1 AT E314345T1
Authority
AT
Austria
Prior art keywords
aromatic
bis
phenyl
disubstituted
hydroxy
Prior art date
Application number
AT00941870T
Other languages
English (en)
Inventor
Donglu Bai
Weizhou Chen
Yunxin Bu
Yiping Wang
Yueli Dong
Aili Kang
Original Assignee
Shanghai Inst Materia Medica
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shanghai Inst Materia Medica filed Critical Shanghai Inst Materia Medica
Application granted granted Critical
Publication of ATE314345T1 publication Critical patent/ATE314345T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/12Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
    • C07D295/135Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/4025Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil not condensed and containing further heterocyclic rings, e.g. cromakalim
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • A61K31/4523Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4545Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring hetero atom, e.g. pipamperone, anabasine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/06Antiarrhythmics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT00941870T 1999-12-10 2000-07-03 N-substituierte benzyl oder phenyl arylsulfamide und ihre verwendung ATE314345T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CNB99124236XA CN1172908C (zh) 1999-12-10 1999-12-10 N-取代苄基或苯基芳香磺酰胺化合物及其用途
PCT/CN2000/000187 WO2001042204A1 (en) 1999-12-10 2000-07-03 N-substituted benzyl or phenyl aromatic sulfamides compounds and the use thereof

Publications (1)

Publication Number Publication Date
ATE314345T1 true ATE314345T1 (de) 2006-01-15

Family

ID=5283321

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00941870T ATE314345T1 (de) 1999-12-10 2000-07-03 N-substituierte benzyl oder phenyl arylsulfamide und ihre verwendung

Country Status (7)

Country Link
US (1) US6605635B1 (de)
EP (1) EP1245561B1 (de)
JP (1) JP4015853B2 (de)
CN (1) CN1172908C (de)
AT (1) ATE314345T1 (de)
DE (1) DE60025270T2 (de)
WO (1) WO2001042204A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002226022A1 (en) * 2000-12-15 2002-06-24 U C B, S.A. Surface functionalization of pigments and/or dyes for radiation curable ink printing and coating applications
RS63699B1 (sr) * 2009-11-17 2022-11-30 Huyabio International Llc Upotreba sulkardina za tretman atrijalne fibrilacije
JP6116907B2 (ja) * 2009-11-17 2017-04-19 フヤ バイオサイエンス インターナショナル エルエルシー サルカルディン及びその塩の緩速点滴
MX2021006933A (es) 2018-12-13 2021-09-30 Huya Bioscience Int Llc Administración de sulcardina para el tratamiento de fibrilación auricular aguda.
BR112021014640A8 (pt) 2019-01-29 2022-12-20 Huya Bioscience Int Llc Sais de sulcardina
EP3968979A4 (de) 2019-05-15 2023-03-01 Bexson Biomedical, Inc. Ketaminformulierung für subkutane injektion
AU2021288056A1 (en) * 2020-06-12 2023-02-09 Huyabio International, Llc Sulcardine administration for treatment of acute atrial fibrillation
CA3198795A1 (en) 2020-11-18 2022-05-27 Jeffrey Becker Complexing agent salt formulations of pharmaceutical compounds

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5059620A (en) * 1985-12-27 1991-10-22 The Du Pont Merck Pharmaceutical Company Aryl substituted aminomethyl benzene derivatives

Also Published As

Publication number Publication date
WO2001042204A1 (en) 2001-06-14
DE60025270T2 (de) 2006-08-17
EP1245561A1 (de) 2002-10-02
DE60025270D1 (de) 2006-02-02
EP1245561A4 (de) 2003-04-23
US6605635B1 (en) 2003-08-12
JP2003516385A (ja) 2003-05-13
JP4015853B2 (ja) 2007-11-28
CN1299813A (zh) 2001-06-20
EP1245561B1 (de) 2005-12-28
CN1172908C (zh) 2004-10-27

Similar Documents

Publication Publication Date Title
ATE428421T1 (de) Medizinische zusammensetzung mit verbesserter stabilität und reduzierten gelierungseigenschaften
DK1712547T3 (da) Bicycloesterderivat
ATE248837T1 (de) Chinuclidin-acrylamide
MA28010A1 (fr) Derives de piperazine et leur utilisation comme agents therapeutiques
NO20082136L (no) 1,5-substituerte indol-2-yl-amidderivater
BR0009410A (pt) Piridina-2,3-dicarboxamida, composto, uso de uma piridina-2,3-dicarboxamida, composição herbicida, composição para a dessecação e/ou desfolhação de vegetais, e, processo para controlar vegetação não desejável
DE60045508D1 (de) Dalda-analoge und ihre verwendung
ATE113936T1 (de) Substituierte n-(1-alkyl-3-hydroxy-4- piperidinyl)benzamide.
ATE314345T1 (de) N-substituierte benzyl oder phenyl arylsulfamide und ihre verwendung
DE69803048D1 (de) Aminosulfonylharnstoffe mit herbizider wirkung
ATE556712T1 (de) A2a antagonisten zur behandlung von motorischen störungen
WO2004041802A8 (en) 4(phenyl-piperazinyl-methyl) benzamide derivatives and their use for the treatment of pain or gastrointestinal disorders
NO20052699L (no) 4(fenylpiperazinyl-metyl)benzamid-derivater og deres anvendelse ved behandling av smerte og gastrointestinale lidelser.
NO20023001L (no) Substituerte piperazinderivater som MTP inhibitorer
ATE327980T1 (de) 3-heterocyclyl-substituierte benzoesäurederivate
ES2124861T3 (es) Derivados de aminoacidos y su utilizacion como inhibidores de la encefalinasa.
DE60123528D1 (de) Verwendung eines Mittels zur Verbesserung der Astrozytenfunktion zur Behandlung von Parkinsons Krankheit
DK0614888T3 (da) Tetrahydrocyclopentab indol-methanaminer og beslægtede forbindelser, en fremgangsmåde til deres fremstilling og deres anvendelse som lægemidler.
ATE88176T1 (de) 2-hydroxy-3-aryloxy-propylaminderivate mit kardiovaskulaerer wirkung.
DK1104419T3 (da) N-substituerede azabicyloheptan-derivater, deres fremstilling og anvendelse
EP1325918A4 (de) Herzmuskelzellen-apoptose hemmstoffe und behandlung/vorbeugung von herzkrankheiten
ATE457305T1 (de) Neue 3-phenylpropionsäurederivate zur behandlung von diabetes
ATE245155T1 (de) N-substituierte 1-(butyrolacton)-isochinoline zur behandlung von nervenstörungen
ATE286728T1 (de) Verwendung von homocysteinderivaten zur behandlung von bakteriellen infektionen
TH65074A (th) วิธีการบำบัด สภาวะที่เกี่ยวเนื่องกับ p38 ไคเนส และสารประกอบพิร์โรโลไทรแอซีนที่มีประโยชน์เป็นสารยับยั้งไคเนส

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties